Francesca Barone M.D., Ph.D.

Company: Candel Therapeutics

Job title: Chief Scientific Officer

Seminars:

Harnessing Oncolytic Viruses to Surpass the ‘Cold’ Tumor Microenvironment 2:30 pm

Design of novel oncolytic viruses to inhibit the immunosuppressive microenvironment, expose multiple tumor antigens and selectively kill cancer cells for an individualized immune response Evaluate viral immunotherapy showing promise in treatment resistant high-grade glioma Review clinical and biomarker data from a phase 1 study of CAN-3110 in recurrent high grade glioma Read more

day: Conference Day 2